APO Research
Talk to an analyst

APO RESEARCH · REPORT

Depression Drugs

Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.

Selected research

Market Structure

Global Depression Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchDepression Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Depression Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Depression Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Depression Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Depression Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.

Global Depression Drugs key players include Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, etc. Global top five manufacturers hold a share over 35%.

North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share about 50%.

Read the full market overview

In terms of product, SSRIs is the largest segment, with a share over 45%. And in terms of application, the largest application is Hospitals, followed by Clinics, etc.

Report Includes

This report provides an overview of the global Depression Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Depression Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Depression Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Depression Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Depression Drugs Segment by Company

Intellipharmaceutics

Pfizer

Eli Lilly

Astrazeneca

Lundbeck

Allergan

GSK

Otsuka Pharmaceutical

Takeda

NHU Group

Shionogi

APOTEX

Kanghong Pharma

HUAHAI

Depression Drugs Segment by Type

SSRIs

SNRIs

Others

Depression Drugs Segment by Application

Hospitals

Clinics

Others

Depression Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Depression Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Depression Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Depression Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Depression Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Depression Drugs industry.

Chapter 3: Detailed analysis of Depression Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Depression Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Depression Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of SSRIs Table 3. Key Players of SNRIs Table 4. Key Players of Others Table 4. Global Depression Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Clinics Table 7. Key Players of Others Table 8. Global Depression Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Depression Drugs Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Depression Drugs Market Share by Region (2021-2026) Table 11. Global Depression Drugs Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Depression Drugs Market Share by Region (2027-2032) Table 13. Depression Drugs Industry Trends Table 14. Depression Drugs Industry Drivers Table 15. Depression Drugs Industry Opportunities and Challenges Table 16. Depression Drugs Industry Restraints Table 17. Global Depression Drugs Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Depression Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Depression Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Depression Drugs Key Company Head Office and Area Served Table 21. Global Depression Drugs Company, Product Type & Application Table 22. Global Depression Drugs Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Depression Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Depression Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Depression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Depression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Depression Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Depression Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Depression Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Depression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Depression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Depression Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Depression Drugs Revenue Market Share by Application (2027-2032) Table 35. Intellipharmaceutics Company Information Table 36. Intellipharmaceutics Business Overview Table 37. Intellipharmaceutics Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Intellipharmaceutics Depression Drugs Product Portfolio Table 39. Intellipharmaceutics Recent Development Table 40. Pfizer Company Information Table 41. Pfizer Business Overview Table 42. Pfizer Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer Depression Drugs Product Portfolio Table 44. Pfizer Recent Development Table 45. Eli Lilly Company Information Table 46. Eli Lilly Business Overview Table 47. Eli Lilly Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eli Lilly Depression Drugs Product Portfolio Table 49. Eli Lilly Recent Development Table 50. Astrazeneca Company Information Table 51. Astrazeneca Business Overview Table 52. Astrazeneca Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Astrazeneca Depression Drugs Product Portfolio Table 54. Astrazeneca Recent Development Table 55. Lundbeck Company Information Table 56. Lundbeck Business Overview Table 57. Lundbeck Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Lundbeck Depression Drugs Product Portfolio Table 59. Lundbeck Recent Development Table 60. Allergan Company Information Table 61. Allergan Business Overview Table 62. Allergan Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Allergan Depression Drugs Product Portfolio Table 64. Allergan Recent Development Table 65. GSK Company Information Table 66. GSK Business Overview Table 67. GSK Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GSK Depression Drugs Product Portfolio Table 69. GSK Recent Development Table 70. Otsuka Pharmaceutical Company Information Table 71. Otsuka Pharmaceutical Business Overview Table 72. Otsuka Pharmaceutical Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Otsuka Pharmaceutical Depression Drugs Product Portfolio Table 74. Otsuka Pharmaceutical Recent Development Table 75. Takeda Company Information Table 76. Takeda Business Overview Table 77. Takeda Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Takeda Depression Drugs Product Portfolio Table 79. Takeda Recent Development Table 80. NHU Group Company Information Table 81. NHU Group Business Overview Table 82. NHU Group Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. NHU Group Depression Drugs Product Portfolio Table 84. NHU Group Recent Development Table 85. Shionogi Company Information Table 86. Shionogi Business Overview Table 87. Shionogi Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Shionogi Depression Drugs Product Portfolio Table 89. Shionogi Recent Development Table 90. APOTEX Company Information Table 91. APOTEX Business Overview Table 92. APOTEX Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. APOTEX Depression Drugs Product Portfolio Table 94. APOTEX Recent Development Table 95. Kanghong Pharma Company Information Table 96. Kanghong Pharma Business Overview Table 97. Kanghong Pharma Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Kanghong Pharma Depression Drugs Product Portfolio Table 99. Kanghong Pharma Recent Development Table 100. HUAHAI Company Information Table 101. HUAHAI Business Overview Table 102. HUAHAI Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. HUAHAI Depression Drugs Product Portfolio Table 104. HUAHAI Recent Development Table 105. North America Depression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Depression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Depression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Depression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Depression Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Depression Drugs Market Size by Country (2021-2026) Table 111. North America Depression Drugs Market Size by Country (2027-2032) Table 112. Europe Depression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Depression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Depression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Depression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Depression Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Depression Drugs Market Size by Country (2021-2026) Table 118. Europe Depression Drugs Market Size by Country (2027-2032) Table 119. China Depression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 120. China Depression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 121. China Depression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 122. China Depression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Depression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Depression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Depression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Depression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Depression Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Depression Drugs Market Size by Country (2021-2026) Table 129. Asia Depression Drugs Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Depression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Depression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Depression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Depression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Depression Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Depression Drugs Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Depression Drugs Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Depression Drugs Product Image Figure 2. Global Depression Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Depression Drugs Market Share by Type: 2025 VS 2032 Figure 4. SSRIs Image Figure 5. SNRIs Image Figure 6. Others Image Figure 7. Global Depression Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Depression Drugs Market Share by Application: 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Others Image Figure 12. Global Depression Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 14. Global Depression Drugs Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Depression Drugs Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Depression Drugs Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Depression Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Depression Drugs Revenue Market Share by Type (2021-2032) Figure 21. Global Depression Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Depression Drugs Revenue Market Share by Application (2021-2032) Figure 23. North America Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 24. North America Depression Drugs Market Share by Type (2021-2032) Figure 25. North America Depression Drugs Market Share by Application (2021-2032) Figure 26. North America Depression Drugs Market Share by Country (2021-2032) Figure 27. United States Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 28. Canada Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Europe Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Depression Drugs Market Share by Type (2021-2032) Figure 32. Europe Depression Drugs Market Share by Application (2021-2032) Figure 33. Europe Depression Drugs Market Share by Country (2021-2032) Figure 34. Germany Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 35. France Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 37. Italy Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Russia Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 40. China Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Depression Drugs Market Share by Type (2021-2032) Figure 42. China Depression Drugs Market Share by Application (2021-2032) Figure 43. Asia Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 44. Asia Depression Drugs Market Share by Type (2021-2032) Figure 45. Asia Depression Drugs Market Share by Application (2021-2032) Figure 46. Asia Depression Drugs Market Share by Country (2021-2032) Figure 47. Japan Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 51. India Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 52. Australia Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Depression Drugs Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Depression Drugs Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Depression Drugs Market Share by Country (2021-2032) Figure 57. Brazil Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 62. UAE Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Chile Depression Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • SSRIs
  • SNRIs
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Intellipharmaceutics
  • Pfizer
  • Eli Lilly
  • Astrazeneca
  • Lundbeck
  • Allergan
  • GSK
  • Otsuka Pharmaceutical
  • Takeda
  • NHU Group
  • Shionogi
  • APOTEX
  • Kanghong Pharma
  • HUAHAI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Depression Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 SSRIs
  5. 1.2.3 SNRIs
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Depression Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Depression Drugs Growth Trends by Region
  14. 1.5.1 Global Depression Drugs Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Depression Drugs Market Size by Region (2021-2026)
  16. 1.5.3 Depression Drugs Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Depression Drugs Market Dynamics
  1. 2.1 Depression Drugs Industry Trends
  2. 2.2 Depression Drugs Industry Drivers
  3. 2.3 Depression Drugs Industry Opportunities and Challenges
  4. 2.4 Depression Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Depression Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Depression Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Depression Drugs Key Company Head office and Area Served
  4. 3.4 Global Depression Drugs Company, Product Type & Application
  5. 3.5 Global Depression Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Depression Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Depression Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Depression Drugs Tier 1, Tier 2, and Tier 3
4 Depression Drugs Market by Type
  1. 4.1 Global Depression Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Depression Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Depression Drugs Market Size Share by Type (2021-2032)
5 Depression Drugs Market by Application
  1. 5.1 Global Depression Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Depression Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Depression Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Intellipharmaceutics
  2. 6.1.1 Intellipharmaceutics Company Information
  3. 6.1.2 Intellipharmaceutics Business Overview
  4. 6.1.3 Intellipharmaceutics Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Intellipharmaceutics Depression Drugs Product Portfolio
  6. 6.1.5 Intellipharmaceutics Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Depression Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eli Lilly Depression Drugs Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Astrazeneca
  20. 6.4.1 Astrazeneca Company Information
  21. 6.4.2 Astrazeneca Business Overview
  22. 6.4.3 Astrazeneca Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Astrazeneca Depression Drugs Product Portfolio
  24. 6.4.5 Astrazeneca Recent Developments
  25. 6.5 Lundbeck
  26. 6.5.1 Lundbeck Company Information
  27. 6.5.2 Lundbeck Business Overview
  28. 6.5.3 Lundbeck Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Lundbeck Depression Drugs Product Portfolio
  30. 6.5.5 Lundbeck Recent Developments
  31. 6.6 Allergan
  32. 6.6.1 Allergan Company Information
  33. 6.6.2 Allergan Business Overview
  34. 6.6.3 Allergan Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Allergan Depression Drugs Product Portfolio
  36. 6.6.5 Allergan Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GSK Depression Drugs Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 Otsuka Pharmaceutical
  44. 6.8.1 Otsuka Pharmaceutical Company Information
  45. 6.8.2 Otsuka Pharmaceutical Business Overview
  46. 6.8.3 Otsuka Pharmaceutical Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Otsuka Pharmaceutical Depression Drugs Product Portfolio
  48. 6.8.5 Otsuka Pharmaceutical Recent Developments
  49. 6.9 Takeda
  50. 6.9.1 Takeda Company Information
  51. 6.9.2 Takeda Business Overview
  52. 6.9.3 Takeda Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Takeda Depression Drugs Product Portfolio
  54. 6.9.5 Takeda Recent Developments
  55. 6.10 NHU Group
  56. 6.10.1 NHU Group Company Information
  57. 6.10.2 NHU Group Business Overview
  58. 6.10.3 NHU Group Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 NHU Group Depression Drugs Product Portfolio
  60. 6.10.5 NHU Group Recent Developments
  61. 6.11 Shionogi
  62. 6.11.1 Shionogi Company Information
  63. 6.11.2 Shionogi Business Overview
  64. 6.11.3 Shionogi Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Shionogi Depression Drugs Product Portfolio
  66. 6.11.5 Shionogi Recent Developments
  67. 6.12 APOTEX
  68. 6.12.1 APOTEX Company Information
  69. 6.12.2 APOTEX Business Overview
  70. 6.12.3 APOTEX Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 APOTEX Depression Drugs Product Portfolio
  72. 6.12.5 APOTEX Recent Developments
  73. 6.13 Kanghong Pharma
  74. 6.13.1 Kanghong Pharma Company Information
  75. 6.13.2 Kanghong Pharma Business Overview
  76. 6.13.3 Kanghong Pharma Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Kanghong Pharma Depression Drugs Product Portfolio
  78. 6.13.5 Kanghong Pharma Recent Developments
  79. 6.14 HUAHAI
  80. 6.14.1 HUAHAI Company Information
  81. 6.14.2 HUAHAI Business Overview
  82. 6.14.3 HUAHAI Depression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 HUAHAI Depression Drugs Product Portfolio
  84. 6.14.5 HUAHAI Recent Developments
7 North America
  1. 7.1 North America Depression Drugs Market Size (2021-2032)
  2. 7.2 North America Depression Drugs Market Size by Type
  3. 7.2.1 North America Depression Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Depression Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Depression Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Depression Drugs Market Size by Application
  7. 7.3.1 North America Depression Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Depression Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Depression Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Depression Drugs Market Size by Country
  11. 7.4.1 North America Depression Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Depression Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Depression Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Depression Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Depression Drugs Market Size (2021-2032)
  2. 8.2 Europe Depression Drugs Market Size by Type
  3. 8.2.1 Europe Depression Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Depression Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Depression Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Depression Drugs Market Size by Application
  7. 8.3.1 Europe Depression Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Depression Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Depression Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Depression Drugs Market Size by Country
  11. 8.4.1 Europe Depression Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Depression Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Depression Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Depression Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Depression Drugs Market Size (2021-2032)
  2. 9.2 China Depression Drugs Market Size by Type
  3. 9.2.1 China Depression Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Depression Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Depression Drugs Market Share by Type (2021-2032)
  6. 9.3 China Depression Drugs Market Size by Application
  7. 9.3.1 China Depression Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Depression Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Depression Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Depression Drugs Market Size (2021-2032)
  2. 10.2 Asia Depression Drugs Market Size by Type
  3. 10.2.1 Asia Depression Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Depression Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Depression Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Depression Drugs Market Size by Application
  7. 10.3.1 Asia Depression Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Depression Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Depression Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Depression Drugs Market Size by Country
  11. 10.4.1 Asia Depression Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Depression Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Depression Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Depression Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Depression Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Depression Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Depression Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Depression Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Depression Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Depression Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Depression Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Depression Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Depression Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Depression Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Depression Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Depression Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Depression Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Depression Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst